TREA

97270447 - CG PHARMACEUTICALS

Follow

Information

  • Trademark
  • 97270447
  • Serial Number
    97270447
  • Filing Date
    February 16, 2022
    2 years ago
  • Transaction Date
    October 03, 2024
    2 months ago
  • Status Date
    October 01, 2024
    2 months ago
  • Published for Opposition Date
    August 08, 2023
    a year ago
  • Location Date
    October 03, 2023
    a year ago
  • Status Code
    731
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    SHOOR, AMIT
  • Attorney Docket Number
    CGPH.019T
    Attorney Name
    Chang Sik Lim
    Law Office Assigned Location Code
    M80
  • Owners
Information
Mark Drawing Code
4
Mark Identification
CG PHARMACEUTICALS
Case File Statements
  • GS0411: Educational services, namely, conducting seminars regarding the use of prescription pharmaceutical products for medical disorders and dissemination of materials in connection therewith; providing motivational and educational speakers featuring information regarding medical disorders; conducting educational seminars in the field of medicine, medical disorders, cancer treatment and diagnosis, biologics, and pharmaceutical products and dissemination of materials in connection therewith; educational services, namely, conducting classes, seminars, conferences or workshops in the field of medicine, medical disorders, cancer treatment and diagnosis, biologics, and pharmaceutical products
  • GS0051: biopharmaceutical preparations for the treatment of cancer; biopharmaceutical preparations for the treatment of chronic diseases, namely, dementia, Alzheimer's disease, arthritis, rheumatoid arthritis, fibrosis, pulmonary fibrosis, idiopathic pulmonary fibrosis, kidney disease, inflammatory bowel disease, gastrointestinal disease, infectious diseases, neurodegenerative diseases, immunological disorders, and inflammatory diseases; biologic preparations for the treatment of cancer; biologic preparations for the treatment of chronic diseases, namely, dementia, Alzheimer's disease, arthritis, rheumatoid arthritis, fibrosis, pulmonary fibrosis, idiopathic pulmonary fibrosis, kidney disease, inflammatory bowel disease, gastrointestinal disease, infectious diseases, neurodegenerative diseases, immunological disorders, and inflammatory diseases; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of chronic diseases, namely, dementia, Alzheimer's disease, arthritis, rheumatoid arthritis, fibrosis, pulmonary fibrosis, idiopathic pulmonary fibrosis, kidney disease, inflammatory bowel disease, gastrointestinal disease, infectious diseases, neurodegenerative diseases, immunological disorders, and inflammatory diseases; pharmaceutical preparations and substances for use in oncology treatment; pharmaceuticals for the treatment of cancer; prescription pharmaceuticals for treatment of diseases and disorders, namely, cancer and chronic diseases
  • GS0441: Providing health and medical information about medical disorders and their diagnosis, prevention and treatment; information and advisory services relating to pharmaceuticals, diseases and medical conditions and treatments, including pharmaceutical advice, medical and pharmaceutical consultation, medical advisory services, and providing medical information, consultancy and advisory services; information and advisory services relating to pharmaceuticals, diseases and medical conditions and treatments, including pharmaceutical advice, medical and pharmaceutical consultation, medical advisory services, and providing medical information, consultancy and advisory services provided on-line over a computer network and the Internet; Providing information regarding medical conditions; medical information services; providing medical information regarding testing, diagnosis, and treatment of diseases; providing medical information to patients regarding disease management and medication
  • DS0000: "PHARMACEUTICALS"
Case File Event Statements
  • 2/19/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 2/22/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/30/2022 - 2 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/1/2022 - 2 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/1/2022 - 2 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 12/1/2022 - 2 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/1/2023 - a year ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/1/2023 - a year ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/2/2023 - a year ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/2/2023 - a year ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/19/2023 - a year ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/8/2023 - a year ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/8/2023 - a year ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/2/2024 - 8 months ago
    15 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 4/2/2024 - 8 months ago
    16 - SOU EXTENSION 1 FILED Type: EXT1
  • 4/2/2024 - 8 months ago
    17 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 4/3/2024 - 8 months ago
    18 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/1/2024 - 2 months ago
    19 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/1/2024 - 2 months ago
    22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/1/2024 - 2 months ago
    20 - SOU EXTENSION 2 FILED Type: EXT2
  • 10/1/2024 - 2 months ago
    21 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 10/3/2023 - a year ago
    14 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM